Preclinical News and Research

RSS
Tel Aviv University researchers develop spring-like fibers to help repair damaged heart tissue

Tel Aviv University researchers develop spring-like fibers to help repair damaged heart tissue

Researchers develop first imaging tool to examine myelin damage in MS

Researchers develop first imaging tool to examine myelin damage in MS

Scientists validate new system for identifying individuals with preclinical Alzheimer's disease

Scientists validate new system for identifying individuals with preclinical Alzheimer's disease

Avon Foundation for Women launches competition to bring emerging breast cancer technologies to market

Avon Foundation for Women launches competition to bring emerging breast cancer technologies to market

Applied Integrin Sciences' drug candidate eliminates ovarian cancer tumors in pre-clinical study

Applied Integrin Sciences' drug candidate eliminates ovarian cancer tumors in pre-clinical study

UdeM's IRIC and Bristol-Myers Squibb identify small molecule drug candidate against novel target

UdeM's IRIC and Bristol-Myers Squibb identify small molecule drug candidate against novel target

LCT successfully implants first patient with potential Parkinson's disease treatment

LCT successfully implants first patient with potential Parkinson's disease treatment

World’s first preclinical Magnetic Particle Imaging (MPI) system announced by Bruker

World’s first preclinical Magnetic Particle Imaging (MPI) system announced by Bruker

Multimodal animal bed introduced by Bruker

Multimodal animal bed introduced by Bruker

ParaVision® 6 software from Bruker introduced at 2013 World Molecular Imaging Congress

ParaVision® 6 software from Bruker introduced at 2013 World Molecular Imaging Congress

arGEN-X and Shire achieve milestone in SIMPLE Antibody R&D collaboration

arGEN-X and Shire achieve milestone in SIMPLE Antibody R&D collaboration

Blood lipid marker may help predict risk for Parkinson's disease

Blood lipid marker may help predict risk for Parkinson's disease

CTI completes sale of 15,000 shares to Quogue Capital

CTI completes sale of 15,000 shares to Quogue Capital

Nanodiamonds could be used to promote bone growth and durability of dental implants

Nanodiamonds could be used to promote bone growth and durability of dental implants

Efficacy and safety data on linagliptin and investigational compound empagliflozin* in various diabetes subpopulations presented by Boehringer Ingelheim and Eli Lilly and Company

Efficacy and safety data on linagliptin and investigational compound empagliflozin* in various diabetes subpopulations presented by Boehringer Ingelheim and Eli Lilly and Company

GW Pharmaceuticals starts GWP42006 Phase 1 clinical trial for epilepsy treatment

GW Pharmaceuticals starts GWP42006 Phase 1 clinical trial for epilepsy treatment

SignaBlok's novel peptide inhibitor of TREM-1 suppresses cancer progression

SignaBlok's novel peptide inhibitor of TREM-1 suppresses cancer progression

Cleveland Clinic creates spin-off company to develop vaccine for preventing breast cancer

Cleveland Clinic creates spin-off company to develop vaccine for preventing breast cancer

VBP15 drug shows early promise for treatment of Duchenne muscular dystrophy

VBP15 drug shows early promise for treatment of Duchenne muscular dystrophy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.